Understanding how the brain fights infections like Toxoplasma gondii
Caspase-8 mediated control of CNS infection
This work explores how a specific protein in brain cells helps protect against infections, especially for people with weakened immune systems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11158980 on NIH RePORTER |
What this research studies
Our brains are very special because many of their cells are long-lasting and cannot be replaced. When an infection like Toxoplasma gondii enters the brain, the immune system needs to fight it without harming these vital cells. This project focuses on a protein called caspase-8, which appears to be crucial for brain cells to defend themselves against such parasites. We are learning how caspase-8 helps control the infection and protect brain cells, even when the immune system is already working hard. This understanding could lead to new ways to protect the brain from serious infections.
Who could benefit from this research
Good fit: This foundational research is relevant to individuals who have or are at risk for central nervous system infections, especially those with conditions like AIDS that weaken the immune system.
Not a fit: Patients without CNS infections or those whose conditions are unrelated to the immune system's ability to fight parasites may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments or strategies to protect the brain from severe infections, particularly for individuals with compromised immune systems.
How similar studies have performed: While the role of caspase-8 in brain infection control is a novel area of focus, programmed cell death mechanisms are known to be important in limiting pathogen spread in other contexts.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Harris, Tajie H. — University of Virginia
- Study coordinator: Harris, Tajie H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.